Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve standalone and consolidated financial ....
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Ltd has informed the stock exchanges that its Board of Directors will meet on Wednesday, November 12, 2025. The main item on the agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Q2 and H1 of FY26). The company has also confirmed that the trading window for insiders remains closed from October 1, 2025 until November 14, 2025, which is 48 hours after the results are declared. This is a routine regulatory filing under SEBI's listing rules and does not contain any financial numbers yet.
No immediate impact on the stock price as this is a standard advance notice. Investors should watch for the actual Q2/H1 FY26 results, which are likely to be released on or shortly after November 12, 2025, for any meaningful business signals.